Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT00373841 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Genomic and Proteomic Analysis of Disease Progression in Idiopathic Pulmonary Fibrosis (IPF)

Study acronym: GAP
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Re-verified, no change to tracked fieldsv19
  2. Site contact updatedv18
  3. Site contact updatedv17
  4. Primary and study completion dates: Jul 2025 to Jul 2030 Site contact updatedv16 Show all 2 changesShow less
    • Site contact updated
  5. Study site revisedv15 Show moreShow less

    See this version in full on ClinicalTrials.gov ↗

Show 13 earlier versionsHide 13 earlier versions
  1. 2 versions Re-verified since Sep 15, 2020, no change to tracked fieldsv13-v14
  2. Primary and study completion dates: Jul 2020 to Jul 2025v12
  3. 2 versions Re-verified since Jul 24, 2017, no change to tracked fieldsv10-v11
  4. Site contact updatedv9
  5. Enrollment target: 150 to 500 Primary and study completion dates: Jul 2015 to Jul 2020 · Site contact updatedv8 Show all 3 changesShow less
    • Primary and study completion dates: Jul 2015 to Jul 2020
    • Site contact updated
  6. Re-verified, no change to tracked fieldsv7
  7. Primary completion date: Jul 2015 Completion date: Jul 2010 to Jul 2015 · Site contact updated · Eligibility criteria expanded, about 2 words · 1 morev6 Show all 5 changesShow less
    • Completion date: Jul 2010 to Jul 2015
    • Site contact updated
    • Eligibility criteria expanded, about 2 words
    • Study description shortened, about 5 words

    See this version in full on ClinicalTrials.gov ↗

  8. Re-verified, no change to tracked fieldsv5
  9. Eligibility criteria expanded, about 6 words Study title expanded, about 3 wordsv4 Show all 2 changesShow less
    • Study title expanded, about 3 words

    See this version in full on ClinicalTrials.gov ↗

  10. Completion date: Apr 2007 to Jul 2010 Site details revised · Eligibility criteria expanded, about 3 wordsv3 Show all 3 changesShow less
    • Site details revised
    • Eligibility criteria expanded, about 3 words

    See this version in full on ClinicalTrials.gov ↗

  11. Completion date: Apr 2007 Site contact updatedv2 Show all 2 changesShow less
    • Site contact updated
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of the study is to identify genetic and biologic markers that may predict the loss of lung function due to idiopathic pulmonary fibrosis. The studies will compare genetic and biologic markers of samples to changes in symptoms. The ultimate goal is to predict if or when patients are likely to experience a rapid decline in lung function due to disease progression.
Trial Details
NCT Number NCT00373841
Lead Sponsor University of Pittsburgh
Conditions Idiopathic Pulmonary Fibrosis
Enrollment 500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov